P

Paradigm Research Professionals, LLC | Oklahoma City, OK

Research site

(Unclaimed)

Location

5400 North Classen Boulevard, Oklahoma City, Oklahoma, United States of America

Site insights

Top conditions

Top treatments

SPN-812

Viloxazine

Rapastinel

Aticaprant

SPD489

SPN-810

Quetiapine XR

Levomilnacipran

JNJ-89495120

Seltorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 32 total trials

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT)

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepres...

Active, not recruiting

Depressive Disorder, Major

Drug: Aticaprant

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. (3112 Ped BPD)

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling

Bipolar I Disorder

Depression

Drug: Placebo

Drug: Cariprazine

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder (Moonlight-1)

The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on...

Enrolling

Depressive Disorder, Major

Drug: JNJ-89495120

Drug: Placebo